Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study

NCT07346534 · tracked via the Priya Life Science China tracker

Sponsor

Shanghai 10th People's Hospital

Phase

Not applicable

Started

2022-06-01

Last updated

2026-01-16

Condition(s) studied

Low Rectal CancerRectal NeoplasmsColorectal Cancer

Investigational drug(s) / intervention(s)

Reinforced Anastomotic Suturing (8-10 Interrupted Sutures)Conventional Laparoscopic Dixon Procedure

Reinforced Anastomotic Suturing (8-10 Interrupted Sutures): After completing the laparoscopic low anterior resection (Dixon procedure) for low rectal cancer, the surgeon performs additional reinforcement of the colorectal anastomosis. This is done by placing 8 to 10 interrupted seromuscular sutures circumferentially around the anastomotic site. The goal of this reinforcement is to enhance anastomotic stability, promote healing, and reduce the risk of anastomotic leakage.

Conventional Laparoscopic Dixon Procedure: Patients undergo standard laparoscopic low anterior resection (Dixon procedure) for low rectal cancer. The colorectal anastomosis is performed using a circular stapler without any additional suturing or reinforcement. This represents the conventional surgical approach widely used in clinical practice.

Study summary

Study Description This prospective, controlled clinical study aims to compare the clinical outcomes of reinforced anastomosis using 8-10 interrupted sutures versus the conventional Dixon procedure in patients undergoing laparoscopic low anterior resection for low rectal cancer. Anastomotic leakage remains one of the most significant postoperative complications following low rectal cancer surgery, particularly in laparoscopic procedures due to limited tactile feedback and maneuverability in the pelvic cavity.

Reinforcement of the anastomotic site through additional interrupted suturing may provide better mechanical strength and improved healing, potentially reducing the incidence of anastomotic leakage and related morbidities. In this study, eligible patients will be assigned to receive either a conventional laparoscopic Dixon procedure or the same procedure with added reinforcement of the anastomosis using 8-10 interrupted sutures circumferentially.

Perioperative outcomes including the rate of anastomotic leakage, postoperative complications, operation time, length of hospital stay, return of bowel function, and quality of life will be assessed and compared between the two groups. The study seeks to provide evidence for optimizing surgical techniques in low rectal cancer treatment and improving patient prognosis.

Eligibility

Sex

ALL

Min age

18 Years

Max age

85 Years

Healthy volunteers

Inclusion Criteria: 1. Age between 18 and 85 years. 2. Diagnosed with low rectal adenocarcinoma located within 7 cm from the anal verge by colonoscopy and biopsy. 3. Scheduled for elective laparoscopic low anterior resection (Dixon procedure). 4. Clinical stage I-III (based on preoperative imaging, e.g., MRI/CT) without distant metastasis. 5. Adequate organ function (hematologic, hepatic, renal) to tolerate surgery. 6. Provided written informed consent and willing to comply with study procedures and follow-up. Exclusion Criteria: 1. Presence of synchronous distant metastases or other malignancies. 2. History of prior pelvic radiotherapy or major pelvic surgery. 3. Severe uncontrolled comorbidities (e.g., severe cardiovascular, respiratory, hepatic or renal insufficiency). 4. Emergency surgery indication (e.g., bowel obstruction, perforation). 5. Pregnancy or breastfeeding. 6. Known allergy or contraindication to anesthesia or surgical materials used. 7. Participation in another interventional clinical trial within the last 3 months.

Primary outcome measure(s)

Incidence of Anastomotic Leakage — Within 30 days postoperatively
Defined as clinically significant leakage confirmed by radiological or surgical evidence, classified according to International Study Group of Rectal Cancer (ISREC) criteria.

Trial sites (1)

Facility	City	Region	Status
Shanghai Tenth People's Hospital	Shanghai	China

More Shanghai 10th People's Hospital trials in China

BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction Recruiting

Evaluating the Diagnostic Performance and Impact on Clinical Outcomes of the NuRapid-CRISPR Pathogen Profile Assay in ICU Patients With Sepsis Starting soon

Study of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population Recruiting

Treatment of Perioperative Neurocognitive Disorders With Olfactory Enrichment Recruiting

Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study Active, not recruiting

Other trials for the same condition

Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer Recruiting

A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation Starting soon

A Community Population Screening Cohort Study Based on Polygene Methylation Detection for Colorectal Cancer in Yangzhou Recruiting

Adjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal Cancer Recruiting

TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07346534 on ClinicalTrials.gov ↗ ← All trials in China